MBX 4291
Asset
GLP-1 and GIP receptor co-agonist
- Stage
- Phase 1
- Modality
- Peptide
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Obesity
Phase 1, Recruiting, NCT07142707, clinicaltrials.gov, Oct 31, 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors12
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.